Greenwich LifeSciences, Inc. (GLSI) - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held by Greenwich LifeSciences, Inc. on December 18, 2025. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "GLSI."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
A total of 8,944,615 shares of common stock were represented at the meeting, constituting a quorum. The following matters were approved:
- Proposal 1 (Election of Directors): All five nominees were elected to serve until the 2026 Annual Meeting or until their successors are qualified. There were zero votes "Against" any nominee.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of MaloneBailey LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2025.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the final composition of the Board of Directors following the election of David McWilliams, Snehal S. Patel, Eric Rothe, F. Joseph Daugherty, M.D., and Kenneth Hallock.
- Confirm the engagement of MaloneBailey LLP for the 2025 fiscal year audit.
- Review the Definitive Proxy Statement filed on November 3, 2025, for detailed background on the proposals.